A
Aleš Linhart
Researcher at First Faculty of Medicine, Charles University in Prague
Publications - 371
Citations - 36568
Aleš Linhart is an academic researcher from First Faculty of Medicine, Charles University in Prague. The author has contributed to research in topics: Fabry disease & Medicine. The author has an hindex of 50, co-authored 333 publications receiving 30467 citations. Previous affiliations of Aleš Linhart include University Hospital of Wales & Charles University in Prague.
Papers
More filters
Journal ArticleDOI
Stručný souhrn doporučení pro dlouhodobou péči o nemocné po infarktu myokardu
Petr Ošťádal,Miloš Táborský,Aleš Linhart,Michal Vrablík,Richard Ceska,Renata Cifkova,Eva Králíková,Věra Adámková,Milan Kvapil,Zorjan Jojko +9 more
Journal ArticleDOI
Five year two center retrospective analysis of patients with toxic digoxin serum concentration.
TL;DR: Weekend/holiday versus weekday hospital discharge and guidline adherence (from the American Heart Association's Get with the Guidelines — Coronary Artery Disease Database).
Journal ArticleDOI
Are pulmonary artery pulsatility indexes able to differentiate chronic pulmonary thromboembolism from pulmonary arterial hypertension? An echocardiographic and catheterization study.
Tomáš Paleček,Pavel Jansa,David Ambroz,Zuzana Hlubocká,Jan Horák,M. Skvarilova,Michael Aschermann,Aleš Linhart +7 more
TL;DR: No cutoff value allowed discriminating between CTEPH and PAH by using echocardiographically or invasively derived pulsatility indices, and no optimal threshold values of these parameters can be given to allow satisfactory discrimination of the two diseases in clinical practice.
Journal ArticleDOI
Endovascular treatment combined with stratified surgery is effective in the management of venous thoracic outlet syndrome complications: a long term ultrasound follow-up study in patients with thrombotic events due to venous thoracic outlet syndrome
Skalická L,Lubanda Jc,Simon Jirát,Petr Varejka,Stanislav Beran,Ondrej Dostal,Pavel Prochazka,Vratislav Mrazek,Aleš Linhart +8 more
TL;DR: It is demonstrated that initial endovascular treatment proposed as first line therapy to highly symptomatic subjects and in those with conservative treatment failure improves the symptoms in 77% of patients avoiding the need of acute surgery.
Journal Article
Effect of warfarin anticoagulation on thrombin generation in patients with idiopathic pulmonary arterial hypertension.
Pavel Jansa,Hrachovinova I,David Ambroz,Jana Marešová,Pavel Poláček,Iveta Simkova,Aleš Linhart,Michael Aschermann +7 more
TL;DR: Low-intensity warfarin anticoagulant treatment with target INR between 1.5 and 2.5 could be effective and sufficient to suppress thrombin generation in patients with idiopathic PAH.